Chengdu Kanghong Pharmaceutical Group Co., Ltd.

This early-stage trial tests whether KHN702 tablets can safely ease moderate to severe pain after surgery. About 24 adults will receive either the drug or a placebo, and researchers will measure pain relief over 48 hours. The goal is to see if this new pill works and is safe enou…

This early-stage study tests the safety and how the body processes KHN707 tablets in 38 healthy Chinese adults aged 18-45. Participants are randomly assigned to receive either the drug or a placebo, and no one knows who gets what. The goal is to check for side effects and measure…